This inventor holds 1 USPTO granted patent. Top assignee: Ratiopharm Gmbh. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Innovations by Peter Kraaβ in Pharmaceutical Preparations
Introduction
Peter Kraaβ is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent related to benzimidazole compounds. His work focuses on enhancing the stability and effectiveness of oral pharmaceutical preparations.
Latest Patents
Peter Kraaβ holds a patent for a pharmaceutical preparation that contains a benzimidazole compound mixed with microcrystalline cellulose. This invention relates to oral pharmaceutical preparations in the form of pellets, where the benzimidazole compound is stabilized by combining it with microcrystalline cellulose. This innovative approach aims to improve the delivery and efficacy of the pharmaceutical product.
Career Highlights
Peter Kraaβ is currently associated with Ratiopharm GmbH, a prominent company in the pharmaceutical industry. His role at Ratiopharm has allowed him to contribute to the development of advanced pharmaceutical solutions. His expertise in the field has been instrumental in driving innovation within the company.
Collaborations
Peter has collaborated with several professionals in his field, including Frank Muskulus and Andrea Burgenmeister. These collaborations have fostered a creative environment that encourages the development of new ideas and solutions in pharmaceutical preparations.
Conclusion
Peter Kraaβ's contributions to the pharmaceutical industry through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to influence the development of effective pharmaceutical preparations.